RE:RE:RE:RE:The dilution is unbelievable Definately one way to approach it, very valid!!
Canna was a disaster upfront, the valuations were bubbled to the max. Shromms stocks will never get there imo, and nor should they. i..e $150, etc...
Very different than canna, the clinical side here trumps the world of LPs.... but rec is a thing and a big one imo.
Regulation plays a huge part in this as well.
CANNA 2.0 imo!!! done better after lessons learned